ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs
The content of this joint guidance was developed by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) with the support of a technical advisory group composed of policy makers, service providers, civil society representatives and preventative health experts from throughout the EU/EEA.
HIV testing in Europe: Evaluating the impact, added value, relevance and usability of the European centre for disease prevention and control (ECDC)’s 2010 HIV testing guidance
Sullivan, A.K., Sperle, I., Raben, D., Amato-Gauci, A.J., Lundgren, J.D., Yazdanpanah, Y., Jakobsen, S.F., Tavoschi, L.
Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: A focus on migrants from anti-HCV endemic countries
Falla, A.M., Ahmad, A.A., Duffell, E., Noori, T., Veldhuijzen, I.K.
Hepatitis B/C in the countries of the EU/EEA: A systematic review of the prevalence among at-risk groups
Falla, A.M., Hofstraat, S.H.I., Duffell, E., Hahné, S.J.M., Tavoschi, L., Veldhuijzen, I.K.
Monitoring response to hepatitis B and C in EU/EEA: testing policies, availability of data on care cascade and chronic viral hepatitis-related mortality – results from two surveys (2016)
Aspinall, E.J., Hutchinson, S.J., Goldberg, D.J., Valerio, H., Mozalevskis, A., Noori, T., Duffell, E., Tavoschi, L.